PDS Biotechnology(PDSB) - 2024 Q3 - Quarterly Results

Exhibit 99.1 PDS Biotech Provides Clinical Programs Update and Reports Third Quarter 2024 Financial Results Conference call and webcast today at 8:30 a.m. Eastern Time PRINCETON, N.J., November 14, 2024 -- PDS Biotechnology Corporation (Nasdaq: PDSB) ("PDS Biotech" or the "Company"), a late-stage immunotherapy company focused on transforming how the immune system targets and kills cancers and the development of infectious disease vaccines, today provided a business update and reported financial results for ...